Business
Clinuvel (ASX:CUV) share price falls despite positive update
The Clinuvel Pharmaceuticals Limited (ASX: CUV) share price is tumbling in early morning trade. This comes despite releasing an update to the market. At the time of writing, the biopharmaceutical company’s shares are swapping hands for $27.99, down 2.3%.
What did Clinuvel announce?
The Clinuvel share price is being weighed down by investors despite the company’s positive announcement.
According to this morning’s release, Clinuvel advised that it has now expanded its DNA repair program. The clinical trials will now evaluate afamelanotide in skin cells which have been damaged by ultraviolet (UV) and sun exposure. Patients suffering from rare…
-
Noosa News15 hours agoWoman dead and man rushed to hospital with gunshot wound following crash near Aussie World on Queensland’s Sunshine Coast
-
General21 hours agoBoy dies after being trapped between rocks off NSW beach
-
Noosa News22 hours agoFarmer Fred Perry’s 30-year conservation project creates bird haven after years of ‘bashing and burning’
-
Noosa News22 hours agoDetectives continue to search for answers on Crystal Beale’s death